MENU
ALGS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aligos Therapeutics (ALGS) Ownership - Who owns Aligos Therapeutics?

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
66
Web
https://www.aligos.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
64.74M
P/E Ratio
N/A
Total Cash
99.1M
Projected Growth
N/A
Total Debt
6.07M
Revenue
2.65M
Risk (Beta)
3.90
Dividend Yield
N/A
Total Cash/Share
16.10
Total Debt/Equity
N/A
Revenue/Share
0.30 USD as % of share price

Fundamentals

ALGS
Capitalization
64.7M
P/E Ratio
N/A
Risk (Beta)
3.90
Dividend Yield
N/A
Total Cash
99.1M
Total Cash/Share
16.10
Total Debt
6.07M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.30%
Revenue
2.65M
ROE
N/A
Book Value
71.8M
P/B Ratio
0.90
Cash Flow
N/A
Earnings
-13.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
4.70
Current Revenue Per Employee
10585.71
Dividends Per Share - Security
N/A
EBITDA
-84.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-87.25
Shares Held By Institutions
26.7M
Shares Outstanding - Current
6.15M
Total Liabilities
37.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-73.594
View a ticker or compare two or three
ALGS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
66
Web
https://www.aligos.com